Can a simple blood test spot ovarian cancer before it starts?
NCT ID NCT07764744
First seen Aug 14, 2026 ยท Last updated Aug 14, 2026
Summary
This study is looking at whether a blood test called Galleri can help detect ovarian cancer early in people with BRCA1 or BRCA2 gene changes, who are at higher risk. Participants will give a blood sample and answer questionnaires about their experience. The study will also check how well the test finds ovarian cancer or precancerous conditions compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Galleri multi-cancer early detection (MCED) blood test
- What this could lead to
- If successful, this could lead to a simple blood test that helps catch ovarian cancer earlier in high-risk individuals, potentially improving outcomes.
- What could go wrong
- This is an early feasibility study with a small number of participants. The test may not be accurate enough for routine use, and results may not apply to the broader population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA 1 GENE MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Weill Cornell Medicine
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could centralized surgery boost ovarian cancer survival?
- Engineered immune cells take aim at Mesothelin-Positive tumors
- New drug combo aims to stall ovarian cancer in patients without common DNA repair flaw
- New drug duo aims to outperform chemo in ovarian cancer
- Blood test may spot ovarian cancer return months before scans
- Doctors' teamwork under the microscope: can better meetings lead to better cancer care?